Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

Clinical trial NCT03426033 · COMPLETED

Trial details

NCT number: NCT03426033
Sponsor: Akcea Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Elevated Lipoprotein(a)Cardiovascular Diseases

Start date: 2017-12-15
Primary completion: 2018-02-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.